RenovoRx regains Nasdaq compliance with $1 minimum bid price rule
RNXT•Nasdaq compliance regained
RenovoRx regained Nasdaq compliance on the $1 minimum bid price rule, removing a delisting risk tied to a December 31, 2025 deficiency notice.
Nasdaq confirmed the stock closed at $1 or higher for 10 straight sessions from Aug. 6 through Aug. 19, 2026.
The listing matter is closed, keeping RNXT on the Nasdaq Capital Market with no change to trading status.
